Anchor Investment Management LLC Sells 204 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Anchor Investment Management LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 5.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,474 shares of the financial services provider’s stock after selling 204 shares during the quarter. Anchor Investment Management LLC’s holdings in iShares Biotechnology ETF were worth $506,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of IBB. BNP Paribas Financial Markets boosted its holdings in iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares during the period. State of Michigan Retirement System lifted its holdings in shares of iShares Biotechnology ETF by 150.0% in the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after purchasing an additional 75,000 shares in the last quarter. Aristides Capital LLC acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at $9,180,000. Finally, Sanctuary Advisors LLC bought a new stake in iShares Biotechnology ETF during the 2nd quarter valued at $8,118,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB opened at $136.61 on Friday. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57. The company’s fifty day moving average price is $141.84 and its two-hundred day moving average price is $142.25.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.